MV

Manuel Vega

HC Hanall Biopharma Co.: 9 patents #3 of 50Top 6%
CB Catalyst Biosciences: 1 patents #19 of 25Top 80%
📍 Vigneux-sur-Seine, FR: #2 of 24 inventorsTop 9%
Overall (All Time): #352,936 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
8383388 Modified coagulation factor IX polypeptides and use thereof for treatment Jorge Oyhenart, Xavier Gallet, Gilles Borrelly, Thierry Guyon, Lila Drittanti 2013-02-26
8252743 Modified erythropoietin polypeptides and uses thereof for treatment Thierry Guyon, Gilles Borrelly, Xavier Gallet, Lila Drittanti 2012-08-28
8222209 Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof Thierry Guyon, Gilles Borrelly, Lila Drittanti 2012-07-17
8114839 Protease resistant modified erythropoietin polypeptides Rene Gantier, Lila Drittanti, Thierry Guyon 2012-02-14
8105573 Protease resistant modified IFN beta polypeptides and their use in treating diseases Rene Gantier, Lila Drittanti, Thierry Guyon 2012-01-31
8057787 Protease resistant modified interferon-beta polypeptides Rene Gantier, Lila Drittanti, Thierry Guyon 2011-11-15
8052964 Interferon-β mutants with increased anti-proliferative activity Rene Gantier, Lila Drittanti, Thierry Guyon 2011-11-08
7998930 Modified growth hormones Thierry Guyon, Gilles Borrelly, Lila Drittanti 2011-08-16
7998469 Protease resistant interferon beta mutants Rene Gantier, Lila Drittanti, Thierry Guyon 2011-08-16
7884073 Modified growth hormone Thierry Guyon, Gilles Borrelly, Lila Drittanti 2011-02-08
7650243 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules Rene Gantier, Lila Drittanti, Thierry Guyon 2010-01-19
7647184 High throughput directed evolution by rational mutagenesis Lila Drittanti 2010-01-12
7611700 Protease resistant modified interferon alpha polypeptides Rene Gantier, Lila Drittanti, Thierry Guyon 2009-11-03
7349812 Method for determining the titer of biological agents in living target cells 2008-03-25